16143-96-7Relevant academic research and scientific papers
A catalyst-free synthesis of asymmetric diaryl ketones from aryltins
Silbestri, Gustavo F.,Masson, Romina Bogel,Lockhart, María T.,Chopa, Alicia B.
, p. 1520 - 1524 (2006)
A series of diaryl ketones have been synthesized in good yields (40-78%) through the catalyst-free reaction of trimethylarylstannanes with aroyl chlorides in chlorobenzene as solvent. In addition, an attractive feature is that these reactions are completely regioselective making possible the synthesis of diarylketones which are not usually available under the influence of the directing forces of the substituents present in the aromatic ring. Also, the reaction conditions are mild enough to be applied to acid sensitive molecules.
Zirconium sulfophenyl phosphonate as a heterogeneous catalyst in tetrahydropyranylation of alcohols and phenols
Curini, Massimo,Epifano, Francesco,Marcotullio, Maria Carla,Rosati, Ornelio,Costantino, Umberto
, p. 8159 - 8162 (1998)
Zirconium Sulfophenyl Phosphonate Zr(O3PCH3)(1.2)(O3PC6- InSO3H)(0.8) was found to be an efficient heterogeneous catalyst for the tetrahydropyranylation of alcohols and phenols.
Discovery of the imidazole-derived GPR40 agonist AM-3189
Ma, Zhihua,Lin, Daniel C.-H.,Sharma, Rajiv,Liu, Jinqian,Zhu, Liusheng,Li, An-Rong,Kohn, Todd,Wang, Yingcai,Liu, Jiwen,Bartberger, Michael D.,Medina, Julio C.,Zhuang, Run,Li, Frank,Zhang, Jane,Luo, Jian,Wong, Simon,Tonn, George R.,Houze, Jonathan B.
, p. 15 - 20 (2015/12/18)
As a follow-up to the GPR40 agonist AMG 837, which was evaluated in clinical trials for the treatment of type II diabetes, further optimization led to the discovery of AM-3189 (13k). AM-3189 is representative of a new class of compounds with minimal CNS penetration, superior pharmacokinetic properties and in vivo efficacy comparable to AMG 837.
